课题基金 / 基金详情

NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES TRIALNET

NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES TRIALNET
1 型糖尿病试验网开发的自然史研究
批准号:
7625818
负责人:
JAN S. ULBRECHT
金额:
$0.91万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

JAN S. ULBRECHT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goals of the TrialNet Natural History Study of the Development of Type 1 Diabetes (T1D) are to both gain information about the pathogenesis and natural history of T1D and to facilitate the recruitment and assessment of individuals who might qualify for T1D prevention trials. Importantly, the information obtained from this study will serve to enable the development and implementation of prevention trials. The overall objective of this study is to perform baseline and repeat assessments over time of the metabolic and immunologic status of individuals at risk for T1D in order to characterize their risk for developing T1D, to describe the pathogenetic evolution of T1D, and to increase the understanding of the pathogenetic factors involved in the development of T1D.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SHADE - STRESS, HEALTH AND DIABETES EXPERIENCE
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES PHASE 1
WRITING AND THE DAILY EXPERIENCE OF ILLNESS
NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES TRIALNET
国内基金
海外基金
水稻边界发育缺陷突变体abnormal boundary development(abd)的基因克隆与功能分析
Development of a Linear Stochastic Model for Wind Field Reconstruction from Limited Measurement Data
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    40万元
  • 批准年份:
    2020
  • 负责人:
    Vikrant Gupta
  • 依托单位: